GtP is a major regulator of multiple cellular processes, but tools for quantitative evaluation of GtP levels in live cells have not been available. We report the development and characterization of genetically encoded GtP sensors, which we constructed by inserting a circularly permuted yellow fluorescent protein (cpYFP) into a region of the bacterial G protein FeoB that undergoes a GtP-driven conformational change. GtP binding to these sensors results in a ratiometric change in their fluorescence, thereby providing an internally normalized response to changes in GtP levels while minimally perturbing those levels. mutations introduced into FeoB to alter its affinity for GtP created a series of sensors with a wide dynamic range. critically, in mammalian cells the sensors showed consistent changes in ratiometric signal upon depletion or restoration of GtP pools. We show that these GtP evaluators (GeVAls) are suitable for detection of spatiotemporal changes in GtP levels in living cells and for high-throughput screening of molecules that modulate GtP levels.
GtP is a major regulator of multiple cellular processes, but tools for quantitative evaluation of GtP levels in live cells have not been available. We report the development and characterization of genetically encoded GtP sensors, which we constructed by inserting a circularly permuted yellow fluorescent protein (cpYFP) into a region of the bacterial G protein FeoB that undergoes a GtP-driven conformational change. GtP binding to these sensors results in a ratiometric change in their fluorescence, thereby providing an internally normalized response to changes in GtP levels while minimally perturbing those levels. mutations introduced into FeoB to alter its affinity for GtP created a series of sensors with a wide dynamic range. critically, in mammalian cells the sensors showed consistent changes in ratiometric signal upon depletion or restoration of GtP pools. We show that these GtP evaluators (GeVAls) are suitable for detection of spatiotemporal changes in GtP levels in living cells and for high-throughput screening of molecules that modulate GtP levels.
GTP regulates a large array of cellular processes ranging from protein synthesis 1 to cell signaling 2, 3 , including activation of G proteins, dysfunction of which underlies a variety of human diseases [4] [5] [6] , most notably cancer 7 . While the need for a method of measuring GTP levels in live cells is clear, no such method currently exists.
We report here the construction of genetically encoded GTP sensors based on fluorescent protein (FP) technology. These sensors exhibit a rapid, internally normalized ratiometric change in fluorescence upon changes in GTP concentration in vitro and in vivo. They also reveal heterogeneity in the intracellular distribution of GTP, raising the possibility that such variation could regulate the activity of G proteins in different cellular compartments. 
construction of the GtP sensor
The G-protein domain of the Escherichia coli iron-transport protein FeoB contains a loop (amino acid residues 35-40) that undergoes a conformational change upon GTP binding 8 (Fig. 1a,b) . As a bacterial protein, FeoB is unlikely to interact specifically with eukaryotic proteins that could confound its function as a GTP sensor. The GTP on and off rates of FeoB are ~10 6 M −1 s −1 and 12 s −1 , respectively 9 , so it can respond quickly to changes in GTP concentration, and its GTP hydrolysis rate is only 0.0015 s −1 , so its hydrolysis activity should not reduce local GTP pools.
DNA encoding cpYFP (ref. 10) was inserted into DNA encoding residues 35-40 of the FeoB G-protein domain (Fig. 1c) . Fusion nomenclature followed the form "FY1a+1a": the number designates the insertion site, with "1" corresponding to insertion after residue 35 and "6" to insertion after residue 40; the first "a" indicates the presence of a Ser-Ala-Gly linker at the cpYFP N terminus; the second "a" indicates a Gly-Thr linker at the cpYFP C terminus. Most of the 24 fusions we generated changed fluorescence upon binding GTP, with three (FY1+1a, FY5a+5a and FY6+6a) showing a more than twofold decrease in emission when excited at 485 nm (Supplementary Fig. 1 ). However, only FY5a+5a showed a ratiometric change, with GTP causing a decrease in fluorescence when the fusion protein was excited at <450 nm and an increase at >450-nm excitation ( Supplementary  Fig. 2a ), resulting in a large change in the ratio of emission intensities at 405-nm and 485-nm excitation (Ex405/Ex485; Fig. 1d ). Such ratiometric changes enable researchers to normalize the signal and correct for variations in sensor levels by measuring the ratio of fluorescence at two wavelengths. The ratiometric signal of FY5a+5a is large, ranging from 1.7 to 5.3 across the relevant pH range (Supplementary Fig. 3 ). For comparison, this signal is over twofold greater than signals achieved by the Perceval 11 and cellular magnesium levels do not affect sensor function Since GTP binds FeoB in complex with Mg 2+ , variations in Mg 2+ concentration could affect sensor fluorescence. We measured the effect of varying Mg 2+ concentration with and without GTP. With 0.1 mM EDTA and no Mg 2+ , GTP failed to induce a change in sensor fluorescence (Fig. 2d,e, red traces) . Addition of 0.25 mM Mg 2+ (yielding 0.15 mM free Mg 2+ after chelation by EDTA) partially restored the GTP-induced change in the 400/485 ratio, and addition of 0.5 mM Mg 2+ (yielding 0.4 mM free Mg 2+ after chelation) restored 85% of the change. The Ex400/Ex485 ratios varied less than 5% when free Mg 2+ ranged from 0.9 mM to 3.9 mM, but higher Mg 2+ (>7.9 mM) reduced this ratio owing to increases in fluorescence at longer excitation wavelengths (Fig. 2d) . Without GTP, excitation spectra did not vary with Mg 2+ concentrations in the 0-to 3.9-mM range, but they showed emission increases at longer excitation wavelengths when the Mg 2+ concentration is >7.9 mM (Fig. 2e) . These data indicate that Mg 2+ is required for the GTP-induced change in fluorescence and that very high Mg 2+ concentrations affect fluorescence independently of GTP. However, both with and without GTP, fluorescence is effectively constant over the Mg 2+ concentration ranges of 0.5-5 mM that prevail in vivo 15 .
A set of GtP sensors with a wide dynamic range
The K d for FeoB binding to GTP is ~4-15 µM (refs. 9,13), but total cellular GTP is typically 300-800 µM (ref. 13) . The tight GTP binding of FeoB could render the sensor insensitive to changes in GTP concentration across physiologically relevant ranges. We therefore created five FY5a+5a variants by introducing mutations to weaken or eliminate GTP binding. We characterized the effective affinities of these fusions for GTP and the most structurally similar cellular ligands (ATP and GDP; Supplementary Fig. 5 and Table 1 ). The K eff values (GTP concentrations required to obtain 50% of the maximal ratiometric signal) for the five GTP-binding variants ranged from 30 to 2,000 µM. The variant mutated to abolish GTP binding showed no response to GTP. We named these fusions GTP evaluators, or GEVALs, with a numbered suffix indicating their GTP K eff value ( Table 1) . The nonbinding variant is named GEVALNull. GEVAL fluorescence is affected by pH ( Supplementary Figs. 3  and 6-8) , a feature common to FP-based ligand sensors 16 . Fluorescent pH sensors or pH-sensitive dyes are often deployed in parallel with ligand sensors to determine whether a change in sensor fluorescence is due to a change in pH or a change in ligand concentration 11 . For GEVALs, the most effective control for pH effects is GEVALNull, since it does not respond to GTP but should respond exactly like the other GEVALs to pH or any other change in the cell environment. If GEVAL fluorescence changes are observed under conditions where GEVALNull fluorescence is constant, then they can be attributed to changes in GTP levels rather than to other effects. To confirm that GEVALNull responds to pH identically to the GTP-sensing fusions, we measured their Ex400/Ex485 ratios as a function of pH and GTP concentration ( Supplementary Fig. 7 ). Without GTP, all the GEVALs exhibited equal Ex400/Ex485 ratios that varied identically as pH varied from 5.5 to 8.5. Upon GTP addition, the ratios increased for all the GEVALs except GEVALNull, with the largest increases seen for the sensors with the highest GTP affinity (Supplementary Fig. 7a-e ). However, the Ex400/Ex485 ratio for GEVALNull remained invariant upon GTP addition (Supplementary Fig. 7 ). The GEVAL sensors were expressed well in E. coli, with no indication of aggregation, but to evaluate this further we measured their apparent molecular weight and polydispersity by dynamic light scattering and found them to be monomeric and monodisperse in solution ( Supplementary Fig. 8b ).
GeVAl sensor response to GtP depletion
We used lentiviral transduction to express GEVAL30, GEVAL530 and GEVALNull (the high-and medium-affinity GTP sensors and the unresponsive negative control, respectively) in SK-Mel-103 human melanoma cells. We verified equivalent expression of all sensors by immunofluorescence and immunoblotting (Fig. 3a) . Cells were then transiently transfected with the pHRed 17 vector (with over 90% efficiency) to control for pH variations (Supplementary Fig. 9a ).
Experiments showing that the sensors do not affect cellular GTP levels and are not affected by autofluorescence and bleed-through are described in Supplementary Note 1.
To assess the sensors' sensitivity, we treated cells expressing GEVAL and pHRed sensors with various concentrations of mycophenolic acid (MPA, an inhibitor of the IMPDH1 and IMPDH2 enzymes involved in synthesis of the GMP precursor XMP) for 48 h to deplete GTP and calculated the Ex405/Ex488 ratio for the GTP sensors and the Ex594/Ex458 ratio for pHRed. To transform the Ex594/Ex458 ratios into pH values, we interpolated underlying data from ref. 17 (Online Methods). The analysis showed no difference in overall cell pH among all populations ( Supplementary Fig. 10a,b) . We verified the functionality of the pHRed sensor by monitoring its response to changes in the pH of the cell medium via addition of NH 4 Cl (20 mM final) followed by acetic acid (10 mM final) as previously described 17 ( Supplementary Fig. 10c,d) .
Importantly, fluorometric ratios of GEVAL30 and GEVAL530 decreased in response to MPA, while GEVALNull did not show any significant difference (Figs.3b,c) . Similar results were obtained in 1× and 5× cells (Supplementary Fig. 9c,g ). Depletion of GTP pools by MPA was verified in parallel by HPLC (Fig. 3d) .
The Ex405/Ex488 ratio of GEVAL30 was highest in the absence of MPA (1.24), which suggests that this sensor is effectively GTP saturated in vivo. This ratio decreased in parallel with GTP depletion by MPA to 1.0 (77% of the original value). GEVAL530's Ex405/Ex488 1,150 ± 100 2,770 ± 300 (GEVAL1150) P12G S14A T17S
2,300 ± 100 3,700 ± 300 (GEVAL2300) P12A S14A T17A NA NA (GEVALNull) NA, not applicable. ratio in untreated cells was lower than that of GEVAL30 (0.75 versus 1.24), suggesting that this weaker sensor is only partially saturated with GTP. The GEVAL530 sensor became apparently void of GTP as the concentration of MPA increased, reaching the same Ex405/Ex488 ratio as the GEVALNull sensor (0.5), which exhibited the lowest ratio irrespective of MPA treatment (Fig. 3b) . Similar results were obtained with another inhibitor of IMPDH1 and IMPDH2, mizoribine 18 ( Supplementary Fig. 11a,b) .
spatio-temporal changes in response to GtP depletion GEVAL-expressing cell populations were imaged at different times after treatment with 1.6 µM MPA (Fig. 3e) . GEVAL30 and GEVAL530 quickly responded to MPA, reaching Ex405/Ex488 values within 4-6 h that were similar to the ratio after long-term treatment (48 h; compare Fig. 3c,e) . GEVALNull activity was unaffected (Fig. 3e) . HPLC was measured in parallel up to 6 h ( Fig. 3f) , at which point GTP depletion was comparable to that achieved after longer MPA treatments (Fig. 3d) .
Next, we imaged individual GEVAL-expressing cells at 30-min intervals after MPA treatment. Cell imaging was followed by pixel-by-pixel calculation of the Ex405/Ex488 ratio and false coloring. The Ex405/Ex488 ratios for GEVAL30 and GEVAL530 decreased rapidly over time ( Fig. 4a and Supplementary  Fig. 11d ). We obtained similar results with mizoribine ( Fig. 4b  and Supplementary Fig. 11c,e) .
We also used ratiometric imaging to assess intracellular variations in GEVAL sensor activity. Cells expressing GEVALNull showed a uniformly low ratio throughout each cell, whereas both GEVAL530 and GEVAL30 cells had pockets with higher and lower Ex405/Ex488 ratios (Fig. 5a) . We also analyzed individual sensors to reveal the dynamic range of each sensor, which allowed us to calculate the exact ratios for different subcellular regions displaying a high or low ratio (Fig. 5b) .
The distributions of per-pixel signal ratios within individual cells harboring GEVAL30 and GEVAL530 had significantly higher skewness values (P < 10 −5 for GEVAL30; P < 0.05 for GEVAL530) and excess kurtosis (P < 10 −5 for both sensors) compared with the cells expressing GEVALNull (Supplementary Fig. 12a,b) , further suggesting that the distribution of GTP in the cell is heterogeneous. This heterogeneity was not due to pH variations, since similar pH values were observed between areas of high and low GEVAL activity (Supplementary Fig. 13 ).
GeVAl sensors' response to increased GtP levels
Cells were imaged after MPA treatment with or without the addition of 100 µM guanosine (to replenish intracellular GTP levels [19] [20] [21] ). MPA treatment decreased the Ex405/Ex488 ratio by up to 34% for GEVAL30 and up to 42% for GEVAL530, and guanosine supplementation fully reversed this effect (Fig. 5c) . Thus, the GEVAL sensors detected both depletion and replenishment of GTP.
In parallel, we predepleted intracellular GTP pools overnight with MPA, then imaged them before and after treatment with either vehicle or 100 µM guanosine. Within 1 h, addition of guanosine increased the activity of GEVAL30 and GEVAL530 but not GEVALNull (Fig. 5d) . Guanosine restored the sensors' activity following GTP depletion (Fig. 5c,d ) but did not increase the basal activity of GEVAL30 and only modestly increased that of GEVAL530 when GTP pools were at their physiological levels (Fig. 5c) . These data suggest that GEVAL30 is GTP saturated at the GTP concentrations normally found in these cells and that GEVAL530 is only partially saturated.
GeVAl sensors' response to genetic depletion of GtP
To evaluate GEVAL's activity in response to genetic depletion of GTP, we transduced cells with a short hairpin RNA (shRNA) that suppresses IMPDH2 expression 22 (Fig. 5e) . IMPDH2 depletion reduced the Ex405/Ex488 ratios of GEVAL30 and GEVAL530 by 16-18%, while GEVALNull's ratio was unaffected (Fig. 5f) . The smaller reduction compared to MPA inhibition of the sensors was consistent with HPLC data (compare the 34% decrease upon IMPDH2 suppression in Fig. 5g with the 53% decrease at 0.8 µM MPA in Fig. 3d ) and could be due to incomplete shRNA depletion of IMPDH2. Importantly, activity of GEVAL sensors in cells expressing shRNA-resistant IMPDH2 cDNA was not affected by the above IMPDH2 shRNA (Supplementary Fig. 14a,b) . GeVAl sensors are suitable for high-throughput screening To assess the sensors' suitability for high-throughput (HTP) screening, we seeded cells expressing GEVAL30 or GEVAL530 in 26 wells of a glass-bottom 96-well plate and treated them with either vehicle or 1.6 µM MPA for 24 h. The center of each well was imaged, ten cells per well were analyzed, and the average of their Ex405/Ex488 ratios was used as the average ratiometric intensity of each well. Z′ values of 0.51 and 0.15 were calculated for GEVAL30 and GEVAL530, respectively ( Supplementary  Fig. 14c,d) , suggesting that GEVAL sensors can be developed for HTP applications.
discussion
Monitoring of cellular GTP currently relies on techniques like HPLC 23 or mass spectrometry (MS) 24 , which cannot be performed in live cells, result in loss of spatial resolution and are prone to artifacts because of the lability of NTPs during extraction 23, 25 . A nanosensor for guanine nucleotides has been constructed via coupling of a dye to an aptamer fused to a graphite sheet 26 . However, this sensor cannot be used quantitatively, cannot be expressed in cells and does not differentiate between guanine, GMP, GDP and GTP. The GEVAL sensors deployed in conjunction with pHRed sensors are capable of detecting not only temporal changes in GTP levels in living cells but also changes in subcellular GTP distribution. In addition, HPLC-or MS-based measurements cannot distinguish between total and free GTP levels. Several recent publications strongly suggest that free GTP levels may be below total levels 19, 27, 28 . This is consistent with our observation that GEVAL30 is sensitive to GTP depletion, even though we had expected that this sensor's low K eff for GTP binding might render it insensitive.
Together, our data reveal that the GEVAL sensors represent a novel set of tools that allows semiquantitative assessment of changes in GTP levels within cell populations and in the intracellular distribution of GTP within individual cells. methods Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. online methods GTP sensor construction. DNA encoding FeoB 8 was synthesized with codons optimized for mammalian expression and cloned into pET15b (Genscript, NJ). DNA encoding FeoB switch I region was engineered to contain NgoMIV and SmaI sites at codons 34/35 and 41/42. FeoB DNA was PCR amplified with forward and reverse primers containing, respectively, XbaI and HindIII restriction sites, and ligated into XbaI/HindIII digested pRSET A (Invitrogen) from which a single NgoMIV site had been removed by site-directed mutagenesis. DNA coding for cpYFP was PCR amplified from the ATP/ADP ratio sensor Perceval 11 (Addgene). For insertion into each position of the FeoB switch I region, we created a total of four PCR products from two forward and two reverse primers that differed in encoding either an additional three (SAG) or two (GT) linker residues at, respectively, the N-or C-terminal points of insertion of the cpYFP. NgoMIV digested PCR products were ligated into NgoMIV/SmaI digested pRSET FeoB plasmid from which the Ngo site had been eliminated. Since the pRSET vectors did not yield strong protein expression, FeoB-cpYFP DNAs were PCR amplified with primers containing NdeI and XhoI restriction sites, digested with NdeI and XhoI and ligated into NdeI/XhoI digested pET32 (EMDMillipore). To generate point mutations in the FeoB component of the sensor to alter its affinity for GTP we performed PCR-mediated mutagenesis using mutagenic primers with the QuikChange Mutagenesis Kit (Stratagene).
Protein expression and purification. pET32 expression vectors were transformed into BL21-DE3 cells and single colonies were grown overnight in Luria Broth with 50µg/ml ampicillin and used to inoculate larger volumes of 2× YT media at 1:100 dilutions. Cells were grown at 37 °C to an OD 600 of 0.6-0.8 and induced with 1 mM IPTG, then transferred to 30 °C and grown for 12-18 h. Cells were harvested by centrifugation at 4 °C and the bright yellow-green cell pellets were re-suspended in 50 mM Tris-HCl, pH 8.3, 200 mM NaCl, 0.1% Tween-20, 10 mM imidazole (lysis buffer). Prior to lysis by sonication (Misonix, CT), PMSF was added to 1 mM. Lysates were clarified by 30 min of centrifugation at 15,000g, and the protein was purified from the supernatants on Ni-NTA resin (Qiagen, CA).
Fluorometry. Fluorescence spectra for purified proteins were measured on Horiba JobinYvon Fluoromax-3 or Shimadzu RF-5301PC spectrofluorometers. GEVAL sensors at 1 µM concentration in 100 mM KCl, 50 mM PIPES, pH 7.0, 5 mM MgCl 2 , and 10% glycerol (buffer A), and in the presence of varying concentrations of different nucleotides (as specified in individual figure legends; mixed and incubated for 5-10 min at room temperature), were excited at 320 nm to 520 nm at room temperature while emission at 530 nm was measured. For experiments in which the effects of Mg 2+ concentration were measured, 0.1 mM EDTA was added to buffer A and 1 M MgCl 2 was added to give total Mg 2+ concentrations of 0, 0.25, 0.5, 1, 2, 4, 18, 16, 32 and 64 mM. The corresponding free Mg 2+ concentrations after chelation by EDTA are listed in Figure 2d ,e. Stop-flow fluorometry data were collected at room temperature on an Applied Photosystems stopped-flow fluorometer equipped with an excitation monochromator and a 515-nm log-pass cutoff filter, with excitation at either 400 or 485 nm, and emission measured at 530 nm. Syringes feeding the stop-flow reactant chambers were filled with either 2 µM GEVAL30 alone or 2µM GEVAL30 plus 100 µM GTP in buffer A, and then reacted with an equal volume of either 200 µM GTP, 1 mM GTP or 2.5 mM GDP, as indicated in figure legends.
Ligand binding assays. Binding assays were done on a BioTek Synergy 2 plate reader at 28 °C. 10-µl aliquots of ligand (GTP, GDP, ATP) in binding buffer at 10× final concentration were pipetted into a 96-well fluorescence plate, and 90 µl of the GTP sensor protein solution at 1.12 µM was added to give a protein concentration of 1 µM. The plate was read with excitation at 485 or 400 nm and excitation at 528 nm. The ratio of the fluorescence from excitation at the two wavelengths was fit to the following equation:
where F R is the fluorescence ratio (F 400 /F 485 ) at a given ligand concentration, F 0 is the fluorescence ratio (F 400 /F 485 ) at zero ligand, F N is the fluorescence ratio normalized to F 0 = 1, K d is the ligand dissociation constant, R = (F 0 /F  ), and F  is the fluorescence ratio (F 400 /F 485 ) at infinite ligand concentration. Kinetic assays were carried out similarly, but with the plate reader set to dispense the sensor and immediately start reading fluorescence at 2-s intervals.
pH dependence of the GTP sensors. The pH dependence of the GTP sensors was measured in 100 mM KCl, 5 mM MgCl 2 , 10% glycerol with the following buffering agents in the specified pH ranges: MES (pH 5.5-6.5), PIPES (pH 7), Tris-HCl (pH 7.5-8.5), and glycineNaOH (pH 9-10); 2 µl of 50 µM protein solutions in water were added to 98 µl of the various pH buffers to give a protein concentration of 1 µM (in the presence or absence of 1 mM GTP), and fluorescence was measured as described for the ligand binding assays.
Dynamic light scattering.
We measured dynamic light scattering on a DynaPro Protein Solutions instrument with 50 µl of a 20 µM protein solution and 10 4 s of acquisition time. Hydrodynamic radii (R h ) and MW were calculated using the DynaPro software assuming an isotropic sphere model and buffer viscosity set to phosphate-buffered saline (PBS) at 25 °C.
Cell lines. SK-Mel-103 human melanoma cell lines were obtained from Sloan Kettering Memorial Cancer Center; HEK293FT were purchased from Clontech (Palo Alto, CA, USA). Cells were cultured in DMEM (Invitrogen, Carlsbad, CA, USA) supplemented with 10% FCS, 2 mM glutamine and penicillin-streptomycin antibiotics. Cells were kept at 37 °C under an atmosphere of 5% carbon dioxide. For cell imaging, 1 h before imaging the cells were rinsed once with PBS and supplemented with an immunofluorescencecompatible media (IFM): FluoroBrite DMEM (Invitrogen) supplemented with 4 mM glutamine, 0.5% FBS, and 20 mM HEPES, pH 7.4. Cell lines were recently authenticated and verified as mycoplasma-free with a MycoAlert mycoplasma detection kit purchased from Lonza (Allendale, NJ, USA; LT07-318).
Antibodies and other reagents. Mycophenolic acid, mizoribine, and guanosine were purchased from Sigma-Aldrich (St. Louis, experiments, as specified in each figure legend). Representation of data as dot-plots and bar-and-whisker graphs is described in figure legends. Statistical analysis was performed using two-tailed Student's t-test (or, where indicated, two-tailed Mann-Whitney test). A two-tailed P value < 0.05 was considered statistically significant for all analyses, and the exact P value for each comparison is reported within each figure.
Data availability. The data that support the findings of this study are available from the corresponding authors upon reasonable request. Additional information can be found in the associated Life Sciences Reporting Summary.
